Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$APLM

Apollomics Inc. Class A Ordinary Shares

XNAS

$14.30+0.63%+$0.0900Prev $14.21LIVE Full chart Live alerts
No recent price bars, the chart lights up when APLM starts printing.

As of the latest tick, APLM is trading at $14.30, up 0.00% versus the previous close of $14.21.

Key Stats

Price
$14.30
Change today
+0.00%
Previous close
$14.21
52-week range
$3.66 – $42.12
Avg daily volume
33K
Exchange
XNAS

Why is $APLM moving today?

Here is the latest on APLM from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for APLM today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

Auto-generated from live scanner data. Not investment advice.

$APLM Sentiment

Neutral
Bearish52Bullish
📰 News: 2 bull · 2 bearToday: +0.6%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$APLM Activity

News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.

Alert· 16h ago 101.9× RVOL
APLM hit 101.944x RVOL at 11:59 AM ET
at $17.50
Alert· 16h ago 24.1× RVOL
APLM hit 24.096x RVOL at 11:57 AM ET
at $17.20
Alert· 16h ago +4.43%
$APLM moved +4.43% in 1 min (Level 1) at 11:56 AM ET
at $17.10
Alert· 16h ago 7.8× RVOL
APLM hit 7.762x RVOL at 11:56 AM ET
at $16.38
News· GlobeNewswire Inc.· 273d ago Bullish
Apollomics, Inc. Company Operational Continuity Update
News· GlobeNewswire Inc.· 299d ago Bearish
Nasdaq Halts Apollomics Inc., Ltd.
News· GlobeNewswire Inc.· 570d ago Bearish
Apollomics Announces Top-line Results for Phase 3 Bridging Trial of Uproleselan in China in Patients with Relapsed or Refractory Acute Myeloid Leukemia
News· GlobeNewswire Inc.· 698d ago Bullish
Apollomics Reports First Half 2024 Financial Results and Highlights Vebreltinib Clinical Progress
News· GlobeNewswire Inc.· 861d ago
Apollomics Appoints Matthew Plunkett, Ph.D. as Chief Financial Officer
News· GlobeNewswire Inc.· 906d ago
Apollomics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
News· GlobeNewswire Inc.· 908d ago
Apollomics to Participate in a Fireside Chat at the B. Riley Securities’ 2024 Virtual Oncology Conference
News· GlobeNewswire Inc.· 922d ago
Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia
Free alerts

Get free $APLM alerts the moment volume spikes

Our scanner flagged $APLM 4 times in the last 30 days. Create a free account to track $APLM, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

APLM stock FAQ

Why is $APLM moving today?

Here is the latest on APLM from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for APLM today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

What is the APLM stock price today?

APLM last traded at $14.30, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

Where can I see live APLM alerts?

The APLM Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged APLM 4 times in the last 30 days.

What exchange is APLM on?

APLM (Apollomics Inc. Class A Ordinary Shares) trades on XNAS.

Is APLM good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge APLM for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.